Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9‐dependent and ‐independent pathways

Previously, we showed that bacterial DNA and vertebrate DNA/cationic liposome complexes stimulate potent inflammatory responses in cultured mouse macrophages. In the present study, we examined whether endocytosis and subsequent acidification are associated with these responses. The endocytosis inhibitor, cytochalasin B, reduced tmor necrosis factor α (TNF‐α) production by a plasmid DNA (pDNA)/cationic liposome complex. The endosomal acidification inhibitor, monensin, inhibited cytokine production by pDNA or a calf thymus DNA/liposome complex. These results suggest, similarly to CpG motif‐dependent responses, that endocytosis and subsequent endosomal acidification are also required for these inflammatory responses. It is intriguing that another inhibitor of endosomal acidification, bafilomycin A, stimulated the production of TNF‐α mRNA and its protein after removal of the pDNA/liposome complex and inhibitors, although it inhibited the release of interleukin‐6. Similar phenomena were observed in the activation of macrophages by CpG oligodeoxynucleotide, calf thymus DNA, and Escherichia coli DNA complexed with liposomes. Moreover, bafilomycin A also induced a high degree of TNF‐α release after stimulation with naked pDNA. These results suggest that bafilomycin A increases TNF‐α production induced by DNA at the transcriptional level via an as‐yet unknown mechanism. Furthermore, we investigated the contribution of Toll‐like receptor 9 (TLR9), the receptor of CpG motifs, to the cell activation by the DNA/cationic liposome complex using the macrophages from TLR9−/− mice. We observed a reduced inflammatory cytokine release from macrophages of TLR9−/− mice compared with wild‐type mice. However, the cytokine production was not completely abolished, suggesting that the DNA/cationic liposome complex can induce macrophage activation via TLR9‐dependent and ‐independent pathways.

[1]  H. Wagner.  Immunobiology of Bacterial CpG-DNA , 2011, Current Topics in Microbiology and Immunology.

[2]  H. Wagner.  The immunobiology of the TLR9 subfamily. , 2004, Trends in immunology.

[3]  Y. Takakura,et al.  Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA , 2004, Immunology.

[4]  S. Akira,et al.  Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  David A. Hume,et al.  The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA1 , 2003, The Journal of Immunology.

[6]  R. Scheule,et al.  DNA sequences in cationic lipid:pDNA-mediated systemic toxicities. , 2003, Human gene therapy.

[7]  M. Hashida,et al.  The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes , 2002, Gene Therapy.

[8]  K. Ishii,et al.  Potential Role of Phosphatidylinositol 3 Kinase, rather than DNA-dependent Protein Kinase, in CpG DNA–induced Immune Activation , 2002, The Journal of experimental medicine.

[9]  R. Vabulas,et al.  Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.

[10]  M. Hashida,et al.  Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. , 2002, Biochemical and biophysical research communications.

[11]  R. Scheule,et al.  Antitumor activity of cationic lipid complexed with immunostimulatory DNA. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Cevayir Coban,et al.  Genomic DNA Released by Dying Cells Induces the Maturation of APCs1 2 , 2001, The Journal of Immunology.

[13]  David J. Chen,et al.  RETRACTED: DNA-PKcs Is Required for Activation of Innate Immunity by Immunostimulatory DNA , 2000, Cell.

[14]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[15]  P. Anderson,et al.  Post-transcriptional regulation of tumour necrosis factor α production , 2000, Annals of the rheumatic diseases.

[16]  J. Kline,et al.  Immune effects and therapeutic applications of CpG motifs in bacterial DNA. , 2000, Immunopharmacology.

[17]  Seng H. Cheng,et al.  Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  N. Restifo,et al.  DNA and RNA-based vaccines: principles, progress and prospects. , 1999, Vaccine.

[19]  L. Manzel,et al.  Immunostimulatory CpG-oligodeoxynucleotides induce a factor that inhibits macrophage adhesion. , 1999, The Journal of laboratory and clinical medicine.

[20]  D. Pisetsky,et al.  The influence of lipofectin on the in vitro stimulation of murine spleen cells by bacterial DNA and plasmid DNA vectors. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[21]  L. Manzel,et al.  Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide. , 1999, Antisense & nucleic acid drug development.

[22]  Y. Tan,et al.  The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. , 1999, Human gene therapy.

[23]  F. Paillard.  CpG: the double-edged sword. , 1999, Human gene therapy.

[24]  Simon C Watkins,et al.  Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[25]  G. Hartmann,et al.  CpG DNA and LPS induce distinct patterns of activation in human monocytes , 1999, Gene Therapy.

[26]  T. Kodama,et al.  Characterization of Plasmid DNA Binding and Uptake by Peritoneal Macrophages from Class A Scavenger Receptor Knockout Mice , 1999, Pharmaceutical Research.

[27]  S. Tunca,et al.  Immunoadjuvant action of plasmid DNA in liposomes. , 1999, Vaccine.

[28]  M. Stedman,et al.  Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. , 1999, Human gene therapy.

[29]  H. Mischak,et al.  CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation , 1998, The EMBO journal.

[30]  A. Krieg,et al.  CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. , 1998, Journal of immunology.

[31]  J. Nordstrom,et al.  Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. , 1998, Journal of immunology.

[32]  M. Hashida,et al.  Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages. , 1998, Biochemical and biophysical research communications.

[33]  D. Gill,et al.  Towards gene therapy for cystic fibrosis: a clinical progress report , 1998, Gene Therapy.

[34]  L. Taichman,et al.  Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy , 1997, Journal of virology.

[35]  M. Imperiale,et al.  Promoter Attenuation in Gene Therapy: Interferon-γ and Tumor Necrosis Factor-α Inhibit Transgene Expression , 1997 .

[36]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[37]  K. Heeg,et al.  Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock , 1997, European journal of immunology.

[38]  R. Scheule,et al.  Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. , 1997, Human gene therapy.

[39]  S. Cross,et al.  The chromosomal distribution of CpG islands in the mouse: evidence for genome scrambling in the rodent lineage. , 1997, Genomics.

[40]  K. Sonehara,et al.  Hexamer palindromic oligonucleotides with 5'-CG-3' motif(s) induce production of interferon. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[41]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Hashida,et al.  Disposition Characteristics of Plasmid DNA in the Single-pass Rat Liver Perfusion System , 1996, Pharmaceutical Research.

[43]  M. Hashida,et al.  The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake , 1995, Pharmaceutical Research.

[44]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[45]  A. Bidani,et al.  Effects of bafilomycin A1 on functional capabilities of LPS‐activated alveolar macrophages , 1995, Journal of leukocyte biology.

[46]  M. Cotten,et al.  Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. , 1994, Gene therapy.

[47]  S. Grinstein,et al.  Relative roles of Na+/H+ exchange and vacuolar‐type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages , 1993, Journal of cellular physiology.

[48]  K. Altendorf,et al.  Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Cooper,et al.  Effects of cytochalasin and phalloidin on actin , 1987, The Journal of cell biology.

[50]  R. Black.  Tumor necrosis factor-alpha converting enzyme. , 2002, The international journal of biochemistry & cell biology.

[51]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[52]  Leaf Huang,et al.  LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth , 1999, Gene Therapy.

[53]  M. Hashida,et al.  Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice , 1999, Gene Therapy.

[54]  A. Moran,et al.  Regulation of intracellular pH in J774 murine macrophage cells: H+ extrusion processes. , 1995, The American journal of physiology.

[55]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.